StockData
BioCorRx Inc. logo

BioCorRx Inc. (BICX) stock

BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.25+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.30MP/E –Yield –

BioCorRx operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

BioCorRx's operating income for the twelve months ending Jun 30, 2026 was -$4.90M. For fiscal 2025 it was -$4.83M. The highest annual figure on record is -$2.18M in fiscal 2016.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$4.83M–
FY2024Dec 31, 2024-$5.12M–
FY2023Dec 31, 2023-$3.79M–
FY2022Dec 31, 2022-$4.70M–
FY2021Dec 31, 2021-$5.51M–
FY2020Dec 31, 2020-$7.49M–
FY2019Dec 31, 2019-$5.56M–
FY2018Dec 31, 2018-$4.63M–
FY2017Dec 31, 2017-$2.89M–
FY2016Dec 31, 2016-$2.18M–
FY2015Dec 31, 2015-$5.12M–
FY2014Dec 31, 2014-$3.05M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.47M–
Q1 FY2026Mar 31, 2026-$956.00K–
Q4 FY2025Dec 31, 2025-$534.19K–
Q3 FY2025Sep 30, 2025-$1.95M–
Q2 FY2025Jun 30, 2025-$1.41M–
Q1 FY2025Mar 31, 2025-$937.95K–
Q4 FY2024Dec 31, 2024-$1.12M–
Q3 FY2024Sep 30, 2024-$1.66M–
Q2 FY2024Jun 30, 2024-$1.37M–
Q1 FY2024Mar 31, 2024-$968.69K–
Q4 FY2023Dec 31, 2023-$822.71K–
Q3 FY2023Sep 30, 2023-$961.87K–
Q2 FY2023Jun 30, 2023-$946.90K–
Q1 FY2023Mar 31, 2023-$1.06M–
Q1 FY2022Mar 31, 2022-$1.12M–
Q2 FY2021Sep 30, 2021-$2.60M–
Q1 FY2021Mar 31, 2021-$1.58M–
Q4 FY2020Dec 31, 2020-$1.77M–
Q3 FY2020Sep 30, 2020-$2.05M–
Q2 FY2020Jun 30, 2020-$2.15M–
Q1 FY2020Mar 31, 2020-$1.52M–
Q4 FY2019Dec 31, 2019-$1.60M–
Q3 FY2019Sep 30, 2019-$885.64K–
Q2 FY2019Jun 30, 2019-$1.60M–
Q1 FY2019Mar 31, 2019-$1.48M–
Q4 FY2018Dec 31, 2018-$1.94M–
Q3 FY2018Sep 30, 2018-$1.40M–
Q2 FY2018Jun 30, 2018-$741.46K–
Q1 FY2018Mar 31, 2018-$538.96K–
Q4 FY2017Dec 31, 2017-$1.03M–
Q3 FY2017Sep 30, 2017-$663.65K–
Q2 FY2017Jun 30, 2017-$786.62K–
Q1 FY2017Mar 31, 2017-$412.34K–
Q4 FY2016Dec 31, 2016-$917.71K–
Q3 FY2016Sep 30, 2016-$517.37K–
Q2 FY2016Jun 30, 2016-$412.29K–
Q1 FY2016Mar 31, 2016-$334.66K–
Q4 FY2015Dec 31, 2015-$696.15K–

More BioCorRx figures

See a number that looks wrong?